{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:52:47Z","timestamp":1768416767238,"version":"3.49.0"},"reference-count":182,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T00:00:00Z","timestamp":1588464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>The current coronavirus COVID-19 pandemic, which originated in Wuhan, China, has raised significant social, psychological and economic concerns in addition to direct medical issues. The rapid spread of severe acute respiratory syndrome-coronavirus (SARS-CoV)-2 to almost every country on the globe and the failure to contain the infections have contributed to fear and panic worldwide. The lack of available and efficient antiviral drugs or vaccines has further worsened the situation. For these reasons, it cannot be overstated that an accelerated effort for the development of novel drugs and vaccines is needed. In this context, novel approaches in both gene therapy and vaccine development are essential. Previous experience from SARS- and MERS-coronavirus vaccine and drug development projects have targeted glycoprotein epitopes, monoclonal antibodies, angiotensin receptor blockers and gene silencing technologies, which may be useful for COVID-19 too. Moreover, existing antivirals used for other types of viral infections have been considered as urgent action is necessary. This review aims at providing a background of coronavirus genetics and biology, examples of therapeutic and vaccine strategies taken and potential innovative novel approaches in progress.<\/jats:p>","DOI":"10.3390\/biomedicines8050109","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T03:29:39Z","timestamp":1588562979000},"page":"109","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Coronavirus Pandemic\u2014Therapy and Vaccines"],"prefix":"10.3390","volume":"8","author":[{"given":"Kenneth","family":"Lundstrom","sequence":"first","affiliation":[{"name":"PanTherapeutics, CH1095 Lutry, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,5,3]]},"reference":[{"key":"ref_1","unstructured":"King, A.M., Lefkowitz, E., Adams, M.J., and Carstens, E.B. (2011). Family Coronaviridae. Ninth Report of the International Committee on Taxonomy of Viruses, Elsevier. International Committee on Taxonomy of Viruses, International Union of Microbiological Societies. Virology Division."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: An Overview of Their Replication and Pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"ref_3","first-page":"257","article-title":"A transmissible gastroenteritis in pigs","volume":"108","author":"Doyle","year":"1946","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virusres.2016.05.023","article-title":"Evolution, antigenicity and pathogenicity of porcine epidemic diarrhea virus","volume":"226","author":"Lin","year":"2016","journal-title":"Virus Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fvets.2019.00053","article-title":"Porcine Hemagglutinating Encephalomyelitis Virus: A Review","volume":"6","author":"Houston","year":"2019","journal-title":"Front. Vet. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1017\/S1466252318000117","article-title":"Bovine-like coronaviruses in domestic and wild ruminants","volume":"19","author":"Amer","year":"2018","journal-title":"Anim. Health Res. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: Update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1099\/vir.0.014282-0","article-title":"Rat respiratory coronavirus infection: Replication in airway and alveolar epithelial cells and the innate immune response","volume":"90","author":"Funk","year":"2009","journal-title":"J. Gen. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1051\/vetres:2006055","article-title":"Coronavirus avian infectious bronchitis virus","volume":"38","author":"Cavanagh","year":"2007","journal-title":"Vet. Res."},{"key":"ref_10","first-page":"255","article-title":"Feline infectious peritonitis","volume":"3","author":"Wolfe","year":"1966","journal-title":"Pathol. Vet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.virol.2017.12.027","article-title":"Feline coronavirus: Insights into viral pathogenesis based on the spike protein structure and function","volume":"517","author":"Jaimes","year":"2018","journal-title":"Virology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0738-081X(86)90045-3","article-title":"Sarcoidosis in various organs","volume":"4","author":"Izumi","year":"1986","journal-title":"Clin. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1128\/JVI.02722-07","article-title":"Identification of a novel coronavirus from a beluga whale by using a panviral microarray","volume":"82","author":"Mihindukulasuriya","year":"2008","journal-title":"J. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1128\/JVI.00631-14","article-title":"Identification of diverse alphacoronaviruses and genomic characterization of a novel severe acute respiratory syndrome-like coronavirus from bats in china","volume":"88","author":"He","year":"2014","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/nm.3985","article-title":"A SARS-like cluster of bat coronaviruses shows potential for human emergence","volume":"21","author":"Menachery","year":"2015","journal-title":"Nat. Med."},{"key":"ref_16","first-page":"165","article-title":"The biology and pathogenesis of coronaviruses","volume":"99","author":"Wege","year":"1982","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF00691421","article-title":"Mechanism of demyelination in JHM virus encephalomyelitis","volume":"24","author":"Lampert","year":"1973","journal-title":"Acta Neuropathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/bmj.3.5568.767","article-title":"Effects of a \u201cnew\u201d human respiratory virus in volunteers","volume":"3","author":"Bradburne","year":"1967","journal-title":"Br. Med. J."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"van der Hoek, L., Sure, K., Ihorst, G., Stang, A., Pyrc, K., Jebbink, M.F., Petersen, G., Forster, J., Berkhout, B., and Uberla, K. (2005). Croup is associated with the novel coronavirus NL63. PLoS Med., 2.","DOI":"10.1371\/journal.pmed.0020240"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3181\/00379727-121-30734","article-title":"A new virus isolated from the human respiratory tract","volume":"121","author":"Hamre","year":"1966","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1098\/rstb.2004.1490","article-title":"Epidemiology, transmission dynamics and control of SARS: The 2002\u20132003 epidemic","volume":"359","author":"Anderson","year":"2004","journal-title":"Philos. Trans. R Soc. London B Biol. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.prrv.2004.07.009","article-title":"The chronology of the 2002\u20132003 SARS mini pandemic","volume":"5","author":"Cherry","year":"2004","journal-title":"Paediatr. Resp. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Aleanizi, F.S., Mohmed, N., Alqahtani, F.Y., and El Hadi Mohamed, R.A. (2017). Outbreak of Middle east respiratory syndrome coronavirus in Saudi Arabia: A retrospective study. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-016-2137-3"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1126\/science.1087139","article-title":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China","volume":"302","author":"Guan","year":"2003","journal-title":"Science"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"14040","DOI":"10.1073\/pnas.0506735102","article-title":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats","volume":"102","author":"Lau","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.1118391","article-title":"Bats are natural reservoirs of SARS-like coronaviruses","volume":"310","author":"Li","year":"2005","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nature12711","article-title":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor","volume":"503","author":"Ge","year":"2013","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMra032498","article-title":"The severe acute respiratory syndrome","volume":"349","author":"Peiris","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e00473-12","DOI":"10.1128\/mBio.00473-12","article-title":"Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans","volume":"3","author":"Lauber","year":"2012","journal-title":"mBio"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1099\/vir.0.81662-0","article-title":"Analysis of human coronavirus 229E spike and nucleoprotein genes demonstrates genetic drift between chronologically distinct strains","volume":"87","author":"Chibo","year":"2006","journal-title":"J. Gen. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.virol.2005.04.010","article-title":"Circulation of genetically distinct contemporary human coronavirus OC43 strains","volume":"337","author":"Vijgen","year":"2005","journal-title":"Virology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3201\/eid2004.131746","article-title":"Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013","volume":"20","author":"Meyer","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3201\/eid2002.131182","article-title":"Replicative Capacity of MERS Coronavirus in Livestock Cell Lines","volume":"20","author":"Eckerle","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1401505","article-title":"Evidence for Camel-to-Human Transmission of MERS Coronavirus","volume":"370","author":"Azhar","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1073\/pnas.1323279111","article-title":"Rapid generation of a mouse model for Middle East respiratory syndrome","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kaplan, E.H. (2020). Containing 2019-nCoV (Wuhan) coronavirus. Health Care Manag. Sci.","DOI":"10.1007\/s10729-020-09504-6"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Yang, Y., Peng, F., Wang, R., Guan, K., Jiang, T., Xu, G., Sun, J., and Chang, C. (2020). The deadly coronavirus; The 2003 SARS epidemic and the 2020 novel coronavirus epidemic in China. J. Autoimmun.","DOI":"10.1016\/j.jaut.2020.102434"},{"key":"ref_40","unstructured":"(2020, April 28). Global Health Policy. Available online: https:\/\/www.google.com\/covid19-map."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Han, Q., Lin, Q., Jin, S., and You, L. (2020). Coronavirus 2019-nCoV: A brief perspective from the front line. J. Infect.","DOI":"10.1016\/j.jinf.2020.02.010"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"s223","DOI":"10.1097\/01.inf.0000188166.17324.60","article-title":"History and recent advances in coronavirus discovery","volume":"24","author":"Kahn","year":"2005","journal-title":"Ped. Infect. Dis. J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.chom.2012.04.011","article-title":"Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology","volume":"11","author":"Zhao","year":"2012","journal-title":"Cell. Host Microbe"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1073\/pnas.0805270106","article-title":"Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirion","volume":"106","author":"Barcena","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1128\/JVI.00645-06","article-title":"Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy","volume":"80","author":"Neuman","year":"2006","journal-title":"J. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0022-2836(87)90422-0","article-title":"Evidence for a coiled-coil structure in the spike proteins of coronaviruses","volume":"196","author":"Luytjes","year":"1987","journal-title":"J. Mol. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1128\/jvi.62.11.4288-4295.1988","article-title":"Specific interaction between coronavirus leader RNA and nucleocapsid protein","volume":"62","author":"Stohlman","year":"1988","journal-title":"J. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/viro.1997.8867","article-title":"Identification of a specific interaction between the coronavirus mouse hepatitis virus A59 nucleocapsid protein and packaging signal","volume":"239","author":"Molenkamp","year":"1997","journal-title":"Virology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1128\/JVI.00100-13","article-title":"Functional analysis of the murine coronavirus genomic RNA packaging signal","volume":"87","author":"Kuo","year":"2013","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jsb.2010.11.021","article-title":"A structural analysis of M protein in coronavirus assembly and morphology","volume":"174","author":"Neuman","year":"2011","journal-title":"J. Struct. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/308751a0","article-title":"Sequence and topology of a model intracellular membrane protein, E1 glycoprotein, from a coronavirus","volume":"308","author":"Armstrong","year":"1984","journal-title":"Nature"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/0042-6822(92)90521-P","article-title":"TGEV corona virus ORF4 encodes a membrane protein that is incorporated into virions","volume":"188","author":"Godet","year":"1992","journal-title":"Virology"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Nieto-Torres, J.L., Dediego, M.L., Verdia-Baguena, C., Jimenez-Guardeno, J.M., Regla-Nava, J.A., Fernandez-Delgado, R., Castano-Rodriguez, C., Alcaraz, A., Torres, J., and Aguilella, V.M. (2014). Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathogens, 10.","DOI":"10.1371\/journal.ppat.1004077"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0042-6822(82)90095-2","article-title":"Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion","volume":"119","author":"Collins","year":"1982","journal-title":"Virology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0042-6822(90)90257-R","article-title":"Deduced sequence of the bovine coronavirus spike protein and identification of the internal proteolytic cleavage site","volume":"176","author":"Abraham","year":"1990","journal-title":"Virology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0042-6822(87)90142-5","article-title":"Primary structure of the glycoprotein E2 of coronavirus MHV-A59 and identification of the trypsin cleavage site","volume":"161","author":"Luytjes","year":"1987","journal-title":"Virology"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Walls, A.C., Park, Y.J., Tortorici, M.A., Wall, A., McGuire, A.T., and Veesler, D. (2020). Structure, Function and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell.","DOI":"10.1101\/2020.02.19.956581"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1128\/JVI.73.5.3737-3743.1999","article-title":"Identification of a coronavirus hemagglutinin-esterase with a substrate specificity different from those of influenza C virus and bovine coronavirus","volume":"73","author":"Klausegger","year":"1999","journal-title":"J. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1128\/jvi.71.7.5277-5286.1997","article-title":"Hemagglutinin-esterase, a novel structural protein of torovirus","volume":"71","author":"Cornelissen","year":"1997","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"15064","DOI":"10.1128\/JVI.79.24.15064-15073.2005","article-title":"Expression of hemagglutinin esterase protein from recombinant mouse hepatitis virus enhances neurovirulence","volume":"79","author":"Kazi","year":"2005","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1128\/jvi.68.9.5403-5410.1994","article-title":"Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein","volume":"68","author":"Kubo","year":"1994","journal-title":"J. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0140-6736(04)16255-7","article-title":"Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome","volume":"363","author":"Cheng","year":"2004","journal-title":"Lancet"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1128\/jvi.68.7.4525-4537.1994","article-title":"Bgp2, a new member of the carcinoembryonic antigen-related gene family, encodes an alternative receptor for mouse hepatitis viruses","volume":"68","author":"Nedellec","year":"1994","journal-title":"J. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1128\/JVI.00676-14","article-title":"Host species restriction of Middle East respiratory syndrome coronavirus through its receptor dipeptidyl peptidase 4","volume":"88","author":"Miazgowicz","year":"2014","journal-title":"J. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","article-title":"The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex","volume":"77","author":"Bosch","year":"2003","journal-title":"J. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1073\/pnas.0809524106","article-title":"Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites","volume":"106","author":"Belouzard","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.virol.2004.11.038","article-title":"Programmed ribosomal frameshifting in decoding the SARS-CoV genome","volume":"332","author":"Baranov","year":"2005","journal-title":"Virology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0092-8674(89)90124-4","article-title":"Characterization of an efficient coronavirus ribosomal frameshifting signal: Requirement for an RNA pseudoknot","volume":"57","author":"Brierley","year":"1989","journal-title":"Cell"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"7716","DOI":"10.1128\/JVI.00549-07","article-title":"An RNA stem-loop within the bovine coronavirus nsp1 coding region is a cis-acting element in defective interfering RNA replication","volume":"81","author":"Brown","year":"2007","journal-title":"J. Virol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1128\/JVI.00263-11","article-title":"An optimal cis-replication stem-loop IV in the 5\u2019 untranslated region of the mouse coronavirus genome extends 16 nucleotides into open reading frame 1","volume":"85","author":"Guan","year":"2011","journal-title":"J. Virol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"12084","DOI":"10.1128\/JVI.00915-09","article-title":"Mouse hepatitis virus stem-loop 2 adopts a Uynmg (U)a-like tetraloop structure that is highly functionally tolerant of base substitutions","volume":"83","author":"Liu","year":"2009","journal-title":"J. Virol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/bs.aivir.2016.08.007","article-title":"Coronavirus cis-Acting RNA Elements","volume":"96","author":"Madhugiri","year":"2016","journal-title":"Adv. Virus Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"6720","DOI":"10.1128\/JVI.77.12.6720-6730.2003","article-title":"Stem-loop III in the 5\u2019 untranslated region is a cisacting element in bovine coronavirus defective interfering RNA replication","volume":"77","author":"Raman","year":"2003","journal-title":"J. Virol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/jvi.65.1.320-325.1991","article-title":"Minus-strand copies of replicating coronavirus mRNAs contain antileaders","volume":"65","author":"Sethna","year":"1991","journal-title":"J. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/JVI.01358-06","article-title":"A contemporary view of coronavirus transcription","volume":"81","author":"Sawicki","year":"2007","journal-title":"J. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1083\/jcb.124.1.55","article-title":"Characterization of the budding compartment of mouse hepatitis virus: Evidence that transport from the RER to the golgi complex requires only one vesicular transport step","volume":"124","author":"Ericsson","year":"1994","journal-title":"J. Cell Biol."},{"key":"ref_78","first-page":"281","article-title":"Replication of coronavirus MHV-A59 in sac- cells: Determination of the first site of budding of progeny virions","volume":"33","author":"Tooze","year":"1984","journal-title":"Eur. J. Cell Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0065-3527(05)64006-7","article-title":"Molecular interactions in the assembly of coronaviruses","volume":"64","author":"Rottier","year":"2005","journal-title":"Adv. Virus Res."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Lu, H. (2020). Drug treatment options for the 2019-new coronavirus (2019.nCoV). Biosci. Trends.","DOI":"10.5582\/bst.2020.01020"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"72","DOI":"10.12688\/f1000research.22211.2","article-title":"Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China","volume":"9","author":"Kruse","year":"2020","journal-title":"F1000Res"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1517\/13543784.15.2.89","article-title":"Antiviral applications of RNAi for coronavirus","volume":"15","author":"Wu","year":"2006","journal-title":"Exp. Opin. Investig. Drugs"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/bs.aivir.2016.08.003","article-title":"Molecular Basis of Coronavirus Virulence and Vaccine Development","volume":"95","author":"Enjuanes","year":"2016","journal-title":"Adv. Virus Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2165\/11204950-000000000-00000","article-title":"Lopinavir\/Ritonavir: A review of its use in the management of HIV-1 infection","volume":"70","author":"Croxtall","year":"2010","journal-title":"Drugs"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/infdis\/jiv392","article-title":"Treatment with Lopinavir\/Ritonavir or Interferon-\u03b21b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset","volume":"212","author":"Chan","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13063-017-2427-0","article-title":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-\u03b21b (MIRACLE) trial: Study protocol for a randomized controlled trial","volume":"19","author":"Arabi","year":"2018","journal-title":"Trials"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruang, L., Song, B., Cai, Y., and Wei, M. (2020). A trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N. Engl. J. Med.","DOI":"10.1056\/NEJMoa2001282"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coviro.2019.04.002","article-title":"Nucleoside analogues for the treatment of coronavirus infections","volume":"35","author":"Prujisssers","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/095632020601700506","article-title":"Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-CoV)","volume":"17","author":"Chu","year":"2006","journal-title":"Antivir. Chem. Chemother."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1016\/j.bmcl.2015.05.039","article-title":"Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity","volume":"25","author":"Peters","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.vetmic.2018.04.026","article-title":"The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and in experimental cat infection studies","volume":"219","author":"Murphy","year":"2018","journal-title":"Vet. Microbiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1473-3099(14)70920-X","article-title":"Ribavirin and interferon alpha-2a for severe Middle East respiratory syndrome coronavirus infection: A retrospective cohort study","volume":"14","author":"Omrani","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"43395","DOI":"10.1038\/srep43395","article-title":"GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo and Paramyxoviruses","volume":"7","author":"Lo","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"104541","DOI":"10.1016\/j.antiviral.2019.104541","article-title":"Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase","volume":"169","author":"Brown","year":"2019","journal-title":"Antiviral Res."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Gordon, C.J., Tchesnokov, E.P., Feng, J.Y., Porter, D.P., and Gotte, M. (2020). The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. J. Biol. Chem.","DOI":"10.1074\/jbc.AC120.013056"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Ko, W.-C., Rolain, J.-M., Lee, N.-Y., Chen, P.L., Huang, C.-T., Lee, P.-I., and Hsueh, P.-R. (2020). Arguments in favour of remdesivir for treating SARS-CoV-2 infections. Int. J. Antimicrob. Agents.","DOI":"10.1016\/j.ijantimicag.2020.105933"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Laborda, P., Wang, S.Y., and Voglmeir, J. (2016). Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity. Molecules, 21.","DOI":"10.3390\/molecules21111513"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3201\/eid1004.030458","article-title":"Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Drugs","volume":"10","author":"Tan","year":"2004","journal-title":"Emerg. Inf. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Haviemik, J., Stefanik, M., Foitikova, M., Kali, S., Tordo, N., Rudolf, I., Hubalek, Z., Eyer, L., and Ruzek, D. (2018). Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses. Viruses, 10.","DOI":"10.20944\/preprints201802.0134.v1"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1038\/s41598-018-27224-4","article-title":"The Antiviral Drug Arbidol Inhibits Zika Virus","volume":"8","author":"Fink","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Deng, L., Li, C., Zeng, Q., Liu, X., Li, X., Zhang, H., Hong, Z., and Xia, J. (2020). Arbidol combined with LPV\/r versus LPV\/r alone against Corona Virus Disease 2019: A retrospective cohort study. J. Infect.","DOI":"10.1016\/j.jinf.2020.03.002"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Gautret, P., Lagier, J.-C., Parola, P., Hoang, V.T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., and Vieira, E.V. (2020). Hydroxychloroquine and azothromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. Int. J. Antimicrob. Agents.","DOI":"10.1101\/2020.03.16.20037135"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Ni, L., Zhou, L., Zhou, M., Zhao, J., and Wang, D.W. (2020). Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan. Front. Med.","DOI":"10.1007\/s11684-020-0757-x"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5582\/bst.2020.01030","article-title":"Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment","volume":"14","author":"Wang","year":"2020","journal-title":"Biosci. Trends"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Hoffmann, M., Kleine-Weber, H., Schroeder, S., Kr\u00fcger, N., Herrler, T., Erichsen, S., Schiergens, T.S., Herrler, G., Wu, N., and Nitsche, A. (2020). SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell.","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/22221751.2020.1729069","article-title":"Potent binding of novel 2019 coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody","volume":"9","author":"Tian","year":"2020","journal-title":"Emerg. Mircobes. Infect."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Gurwitz, D. (2020). Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev. Res.","DOI":"10.1002\/ddr.21656"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Wang, C., Li, W., Drabek, D., Okba, N.M.A., van Haperen, R., Osterhaus, A.D., van Kupperveld, F., Haagmans, B.L., Grosveld, F., and Bosch, B.-J. (2020). A human monoclonal antibody blocking SARS-CoV infection. bioRxiv, preprint.","DOI":"10.1101\/2020.03.11.987958"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chlkoroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol. J."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"105923","DOI":"10.1016\/j.ijantimicag.2020.105923","article-title":"Chloroquine for the 2019 novel coronavirus SARS-CoV-2","volume":"55","author":"Colson","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Zhou, D., Dai, S.M., and Tong, Q. (2020). COVID-19: A recommendation to examine the effect of hydrochloroquine in preventing infection and progression. J. Antimicrob. Chemother., 114.","DOI":"10.1093\/jac\/dkaa114"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Di Pierro, F., Bertuccioli, A., and Cavecchia, I. (2020). Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus. Minerva. Gastoenterol. Dietol.","DOI":"10.23736\/S1121-421X.20.02697-5"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Ding, Y., Zeng, L., Li, R., Chen, Q., Zhou, B., Chen, Q., Cheng, P.L., Yutao, W., Zheng, J., and Yang, Z. (2017). The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function. BMC Complement Altern. Med., 17.","DOI":"10.1186\/s12906-017-1585-7"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2165\/00003495-200565180-00012","article-title":"Losartan: A review of its use in stroke risk reduction in patients with hypertension and left ventricular hypertrophy","volume":"65","author":"Moen","year":"2005","journal-title":"Drugs"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"elegans heterochronic gene lin-4 encodes small RNAs with antisense complimentary to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/157016311795563857","article-title":"Micro-RNA in disease and gene therapy","volume":"8","author":"Lundstrom","year":"2011","journal-title":"Curr. Drug Discov. Technol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0168-9525(02)00005-7","article-title":"Mammalian RNAi for the masses","volume":"19","author":"Shi","year":"2003","journal-title":"Trends Genet."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-5793(04)00087-0","article-title":"Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference","volume":"560","author":"Zhang","year":"2004","journal-title":"FEBS Lett."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/135965350400900310","article-title":"Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus","volume":"9","author":"Zheng","year":"2004","journal-title":"Antivir. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.gt.3302682","article-title":"Can siRNA conquer SARS?","volume":"13","author":"Chang","year":"2006","journal-title":"Gene Ther."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10096-008-0495-5","article-title":"siRNA silencing of angiotensin-converting enzyme 2 reduced severe acute respiratory syndrome-associated coronavirus replications in Vero cells","volume":"27","author":"Lu","year":"2008","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-1-4939-2438-7_19","article-title":"Investigation of the functional roles of host cell proteins involved in coronavirus infection using highly specific and scalable RNA interference (RNAi) approach","volume":"1282","author":"Millet","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12539-015-0266-9","article-title":"Design of Potential RNAi (miRNA and siRNA) Molecules for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Gene Silencing by Computational Method","volume":"7","author":"Nur","year":"2015","journal-title":"Interdiscip. Sci."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vetmic.2014.12.009","article-title":"Combination siRNA therapy against feline coronavirus can delay the emergence of antiviral resistance in vitro","volume":"176","author":"McDonagh","year":"2015","journal-title":"Vet. Microbiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s11262-019-01701-y","article-title":"Short hairpin RNAs targeting M and N genes reduce replication of porcine deltacoronavirus in ST cells","volume":"55","author":"Gu","year":"2019","journal-title":"Virus Genes"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.antiviral.2019.03.010","article-title":"Significant inhibition of re-emerged and emerging swine enteric coronavirus in vitro using the multiple shRNA expression vector","volume":"166","author":"Li","year":"2019","journal-title":"Antiviral. Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/1381612823666171109112307","article-title":"Design and Delivery of Therapeutic siRNAs: Application to MERS-Coronavirus","volume":"24","author":"Sohrab","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_129","first-page":"695","article-title":"Inactivated virus vaccines: From chemistry to prophylaxis: Merits, risks and challenges. Expert Rev","volume":"11","author":"Delrue","year":"2012","journal-title":"Vaccines"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12250-012-3241-1","article-title":"Developments of subunit and VLP vaccines against influenza A virus","volume":"27","author":"Deng","year":"2012","journal-title":"Virol. Sin."},{"key":"ref_131","first-page":"109","article-title":"A candidate modified-live bovine coronavirus vaccine: Safety and immunogenicity evaluation","volume":"32","author":"Decaro","year":"2009","journal-title":"New Microbiol."},{"key":"ref_132","unstructured":"(2020, March 25). Bovilis\u00ae Coronavirus. Available online: https:\/\/www.merck-animal-health-usa.com\/product\/cattle\/Bovilis-Coronavirus\/1."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1292\/jvms.17-0414","article-title":"Antibody response to equine coronavirus in horses inoculated with a bovine coronavirus vaccine","volume":"79","author":"Nemoto","year":"2017","journal-title":"Vet. Med. Sci."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-1-0716-0389-5_4","article-title":"A Computational Vaccine Design Approach for MESR-CoV Infections","volume":"2131","author":"Ibrahim","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Battacharaya, M., Sharma, A.R., Patra, P., Ghosh, P., Sharma, G., Patra, B.C., Lee, S.S., and Chakraborty, C. (2020). Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-CoV-2): Immunoinformatics approach. J. Med. Virol.","DOI":"10.1002\/jmv.25736"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12967-019-2116-8","article-title":"Epitope-based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: An immune-informatics study","volume":"17","author":"Tahir","year":"2019","journal-title":"J. Transl. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.2147\/IDR.S175114","article-title":"Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach","volume":"11","author":"Srivastava","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/j.celrep.2019.08.052","article-title":"Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTD","volume":"28","author":"Wang","year":"2019","journal-title":"Cell Rep."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nsmb.3293","article-title":"Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy","volume":"23","author":"Walls","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Ahmed, S.F., Quadeer, A.A., and McKay, M.R. (2020). Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies. Viruses, 12.","DOI":"10.1101\/2020.02.03.933226"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1089\/dna.2007.0616","article-title":"Optimization of a DNA vaccine against SARS","volume":"26","author":"Zakhartchouk","year":"2007","journal-title":"DNA Cell Biol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.virol.2007.01.012","article-title":"Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS","volume":"363","author":"Callendret","year":"2007","journal-title":"Virology"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Shim, B.S., Park, S.M., Quan, J.S., Jere, D., Chu, H., Song, M.K., Kim, D.W., Jang, Y.S., Yang, M.S., and Han, S.H. (2010). Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus\/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses. BMC Immunol., 11.","DOI":"10.1186\/1471-2172-11-65"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.vetimm.2013.01.009","article-title":"A DNA prime-protein boost vaccination strategy targeting turkey coronavirus spike protein fragment containing neutralizing epitope against infectious challenge","volume":"152","author":"Chen","year":"2013","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4149\/av_2019_310","article-title":"Efficacy and immunogenicity of a live L. acidophilus expressing SAD epitope of transmissible gastroenteritis virus as an oral vaccine","volume":"63","author":"Xue","year":"2019","journal-title":"Acta Virol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.vaccine.2018.02.065","article-title":"Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen","volume":"36","author":"Nyon","year":"2018","journal-title":"Vaccine"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1177\/153537020623100808","article-title":"Accumulation of recombinant SARS-CoV spike protein in cytosol and chloroplasts indicate potential for development of plant-derived oral vaccines","volume":"231","author":"Li","year":"2006","journal-title":"Exp. Biol. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1073\/pnas.0503760102","article-title":"Severe acute respiratory syndrome (SARS) S protein production in plants: Development of recombinant vaccine","volume":"102","author":"Pogrebnyak","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1016\/j.vaccine.2009.05.073","article-title":"Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice","volume":"27","author":"Zheng","year":"2009","journal-title":"Vaccine"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00705-019-04492-7","article-title":"Recombinant adenovirus carrying a core neutralizing epitope of porcine epidemic diarrhea virus and heat-labile enterotoxin B of Escherichia coli as a mucosal vaccine","volume":"165","author":"Do","year":"2020","journal-title":"Arch. Virol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.aad1283","article-title":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels","volume":"351","author":"Haagmans","year":"2016","journal-title":"Science"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Veit, S., Jany, S., Fux, R., Sutter, G., and Volz, A. (2018). CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Delivered by Vaccinia Virus MVA in Mice. Viruses, 10.","DOI":"10.3390\/v10120718"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1099\/vir.0.80844-0","article-title":"A single imunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies","volume":"86","author":"Faber","year":"2005","journal-title":"J. Gen. Virol."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Deming, D., Sheahan, T., Heise, M., Yount, B., Davis, N., Sims, A., Suthar, M., Harkema, J., Whitmore, A., and Pickles, R. (2006). Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants. PLoS Med., 3.","DOI":"10.1371\/journal.pmed.0030525"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1128\/JVI.01805-10","article-title":"Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus","volume":"85","author":"Sheahan","year":"2011","journal-title":"J. Virol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nbt0102-20","article-title":"Protein delivery using VP22","volume":"20","author":"Bennett","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-59745-181-9_20","article-title":"Engineering infectious cDNAs of coronavirus as bacterial artificial chromosomes","volume":"454","author":"Almazan","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Shanmugarai, B., Malla, A., and Phoolcharoen, W. (2020). Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development. Pathogens, 9.","DOI":"10.3390\/pathogens9020148"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Lundstrom, K. (2019). RNA Viruses as Tools in Gene Therapy and Vaccine Development. Genes, 10.","DOI":"10.3390\/genes10030189"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Lundstrom, K. (2019). Plasmid DNA-based Alphavirus Vaccines. Vaccines, 7.","DOI":"10.3390\/vaccines7010029"},{"key":"ref_161","first-page":"w20249","article-title":"Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis?","volume":"150","author":"Francesco","year":"2020","journal-title":"Swiss. Med. Wkly."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.micinf.2020.02.006","article-title":"Is COVID-19 receiving ADE from other coronaviruses?","volume":"22","author":"Tetro","year":"2020","journal-title":"Microbes. Inf."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"e02015-19","DOI":"10.1128\/JVI.02015-19","article-title":"Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry","volume":"94","author":"Wan","year":"2020","journal-title":"J. Virol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1146\/annurev-immunol-032712-100019","article-title":"T cell-mediated host immune defenses in the lung","volume":"31","author":"Chen","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2000607","DOI":"10.1183\/13993003.00607-2020","article-title":"Pathogenesis of COVID-19 from a cell biologic perspective","volume":"55","author":"Mason","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Bloch, E.M., Shoham, S., Casadevall, A., Sachais, B.S., Shaz, B., Winters, J.L., van Burskirk, C., Grossman, B.J., Joyner, M., and Henderson, J.P. (2020). Deployment of convalescent plasma for the prevention and treatment of COVID-19. J. Clin. Investig., 138745.","DOI":"10.1172\/JCI138745"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Zhang, L., Pang, R., Xue, X., Bao, J., Ye, S., Daj, Y., Zheng, Y., Fu, Q., Hu, Z., and Yi, Y. (2020). Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19. Aging, 12.","DOI":"10.18632\/aging.103102"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., Wang, F., Li, D., Yang, M., and Xing, L. (2020). Treatment of 5 Critically Ill Patients with COVID-19 With Convalescent Plasma. JAMA.","DOI":"10.1001\/jama.2020.4783"},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., Feldt, T., Green, G., Green, M.L., and Lescure, F.X. (2020). Compassionate Use of Remdesivir for Patients with COVID-19. N. Engl. J. Med.","DOI":"10.1056\/NEJMoa2007016"},{"key":"ref_170","unstructured":"(2020, April 30). Available online: www.gilead.com\/news-and-press\/company-statements\/gilead-sciences-statement-on-data-from-remdesivir-study-in-patients-with-severe-covid-19-in-china."},{"key":"ref_171","unstructured":"(2020, April 30). Available online: www.theguardian.com\/world\/2020\/apr\/23\/high-hopes-drug-for-covid-19-treatment-failed-in-full-trial."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"m1432","DOI":"10.1136\/bmj.m1432","article-title":"Chloroquine and hydroxychloroquine in COVID-19","volume":"369","author":"Ferner","year":"2020","journal-title":"BMJ"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci. Trends"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Chen, Z., Hu, J., Zhang, Z., Jiang, S., Han, S., Yan, D., Zhuang, R., Hu, B., and Zhang, Z. (2020). Efficacy of hydroxychloroquine in patients with COVID-19: Results of a randomized clinical trial. Version 2. medRxiv.","DOI":"10.1101\/2020.03.22.20040758"},{"key":"ref_175","unstructured":"Yan, D., and Zhang, Z. (2020, April 28). Therapeutic Effect of Hydroxychloroquine on Novel Coronavirus Pneumonia (COVID-19). Available online: http:\/\/www.chictr.org.cn\/showproj.aspx?proj=48880."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2230.2001.00857-3.x","article-title":"Fatal toxic epidermal necrolysis associated with hydroxychloroquine","volume":"26","author":"Murphy","year":"2001","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gut.35.4.569","article-title":"Fulminant hepatic failure secondary to hydroxychloroquine","volume":"35","author":"Makin","year":"1994","journal-title":"Gut"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Chorin, E., Dai, M., Shulman, E., Wadhwani, L., Bar-Cohen, R., Barbhayia, C., Aizer, A., Holmes, D., Bernstein, S., and Spinelli, M. (2020). The QT interval in patients with SARS-CoV-2 infection treated with hydroxychloroquine\/azithromycin. medRxiv.","DOI":"10.1101\/2020.04.02.20047050"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Li, Y., Xie, Z., Lin, W., Cai, W., Wen, C., Guan, Y., Mo, X., Wang, J., Wang, Y., and Peng, P. (2020). An exploratory randomized, controlled study on the efficacy and safety of lopinavir\/ritonavir or arbidol treating adult patients hospitalized with mild\/moderate COVID-19 (ELACOI). medRxiv.","DOI":"10.1101\/2020.03.19.20038984"},{"key":"ref_180","unstructured":"(2020, April 28). Available online: www.who.int\/blueprint\/priority-diseases\/key-action\/novel-coronavirus-landscape-ncov.pdf."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1126\/science.abb3088","article-title":"COVID-19 drives new threats to bats in China","volume":"367","author":"Zhao","year":"2020","journal-title":"Science"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/d41586-020-00548-w","article-title":"Mystery deepens over animal source of coronavirus","volume":"579","author":"Cyranoski","year":"2020","journal-title":"Nature"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/8\/5\/109\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:52:26Z","timestamp":1760363546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/8\/5\/109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,3]]},"references-count":182,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5]]}},"alternative-id":["biomedicines8050109"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines8050109","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,3]]}}}